» Articles » PMID: 30166499

A Causal Link Between Oxidative Stress and Inflammation in Cardiovascular and Renal Complications of Diabetes

Overview
Journal Clin Sci (Lond)
Date 2018 Sep 1
PMID 30166499
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic renal and vascular oxidative stress in association with an enhanced inflammatory burden are determinant processes in the development and progression of diabetic complications including cardiovascular disease (CVD), atherosclerosis and diabetic kidney disease (DKD). Persistent hyperglycaemia in diabetes mellitus increases the production of reactive oxygen species (ROS) and activates mediators of inflammation as well as suppresses antioxidant defence mechanisms ultimately contributing to oxidative stress which leads to vascular and renal injury in diabetes. Furthermore, there is increasing evidence that ROS, inflammation and fibrosis promote each other and are part of a vicious connection leading to development and progression of CVD and kidney disease in diabetes.

Citing Articles

Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies.

Karakasis P, Theofilis P, Patoulias D, Vlachakis P, Antoniadis A, Fragakis N Int J Mol Sci. 2025; 26(5).

PMID: 40076813 PMC: 11900163. DOI: 10.3390/ijms26052196.


N-benzyl-N-methyldecane-1-amine derived from garlic ameliorates UVB-induced photoaging in HaCaT cells and SKH-1 hairless mice.

Budluang P, Kim J, Park E, Seol A, Jang H, Kang M Sci Rep. 2025; 15(1):6979.

PMID: 40011526 PMC: 11865569. DOI: 10.1038/s41598-025-88634-9.


Uncovering the mechanism of Huangkui capsule in the treatment of diabetic kidney disease based on network pharmacology and experimental validation.

Liu J, Li Z, Zhang Z, Shen Z Sci Rep. 2025; 15(1):6503.

PMID: 39987179 PMC: 11846948. DOI: 10.1038/s41598-025-91264-w.


Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications.

Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Lorenzo G Antioxidants (Basel). 2025; 14(1).

PMID: 39857406 PMC: 11759781. DOI: 10.3390/antiox14010072.


High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury.

Datta S, Rahman M, Koka S, Boini K Front Pharmacol. 2025; 15:1540639.

PMID: 39840112 PMC: 11747285. DOI: 10.3389/fphar.2024.1540639.